Core Concepts
Clinics are successfully integrating long-acting antiretrovirals into their care programs, improving patient outcomes and satisfaction.
Abstract
New long-acting cabotegravir formulation available for HIV treatment.
Whitman-Walker Health Center integrates long-acting injections into peer staff program.
Training program for peer workers includes various components.
High retention rates and client satisfaction reported.
Challenges and benefits of long-acting injectables discussed.
San Francisco General Hospital Clinic offers injections to patients with viremia.
Positive outcomes and low virological failure rates observed.
Motivation and satisfaction among patients receiving injections highlighted.
Stats
"139 people have received long-acting injections at the clinic since the program launched with a total of 314 injections administered."
"Retention for the second injection was 95%, with 91% of injections given within the 14-day window."
"For the third injection, retention was 91%, with 63% given within the window."
"The overall virological failure rate was 1.5%, which was equivalent to that seen in clinical trials in virologically suppressed individuals."
"73% of people attended their injection appointments on time."
Quotes
"Our retention is going to be the highest compared to other clinics because your peer, your friend, is reminding you and comforting you and telling you, 'Don't worry, I'm on the injection too.'" - Rupa Patel
"We don't call people hard to reach, we call them hardly reached because it's not their fault." - Monica Gandhi
"They are virologically suppressed, so it feels so amazing. They're self-motivated for the first time to want to get an injection." - Monica Gandhi